Browsing Health Sciences and Technology - Master's degree by Title
Research and Teaching Output of the MIT Community
- Home
- →
- MIT Libraries
- →
- MIT Theses
- →
- Theses - Harvard-MIT Division of Health Sciences and Technology
- →
- Health Sciences and Technology - Master's degree
- →
- Browsing Health Sciences and Technology - Master's degree by Title
JavaScript is disabled for your browser. Some features of this site may not work without it.
Browsing Health Sciences and Technology - Master's degree by Title
-
(Massachusetts Institute of Technology, 2004)Patients and their family members are increasingly turning to the Internet for health information. However, the search strategies consumers are using to obtain information are often unsuccessful. Since some patients are ...
-
(Massachusetts Institute of Technology, 2005)Cancer development and progression typically features genomic instability frequently resulting in genomic changes involving DNA copy number gains or losses. Identifying the genomic location of these regional alterations ...
-
(Massachusetts Institute of Technology, 2005)Background A number of important applications in medicine and biomedical research, including quality of care surveillance and identification of prospective study subjects, require identification of large cohorts of patients ...
-
(Massachusetts Institute of Technology, 2006)Cardiac arrhythmias are characterized by a disruption or abnormal conduction of electrical signals within the heart. Treatment of arrhythmias has dramatically evolved over the past half-century, and today, minimally-invasive ...
-
(Massachusetts Institute of Technology, 2011)Founders of new ventures in the medical technology (Medtech) industry require capital to establish, sustain, and grow their companies. Most founders must seek some form of external capital to meet these demands; in Medtech, ...
-
(Massachusetts Institute of Technology, 2011)The aim of this thesis was to look at the impact of acquiring the CE marking approval on the outcome of early stage medical device companies, specifically its impact on strategic acquisition opportunities and on valuation. ...
-
(Massachusetts Institute of Technology, 2010)The Massachusetts Pharmaceutical and Medical Device Manufacturer Code of Conduct (PCOC) or 105 CMR 970.000 was enacted by the Massachusetts state legislature and adopted by the Department of Public Health (DPH) in July ...
-
(Massachusetts Institute of Technology, 1999)
-
(Massachusetts Institute of Technology, 2004)Drug development in the United States is a lengthy and expensive endeavor. It is estimated that average development times range from eleven to fifteen years and exceed costs of one billion dollars. The development pathway ...
-
(Massachusetts Institute of Technology, 2005)Hepatocytes are widely used in the pharmaceutical and medical fields for drug metabolism studies, bioartificial liver devices, and repopulation of damaged livers as an alternative to transplantation. However, these cells ...
-
(Massachusetts Institute of Technology, 2008)Alzheimer's disease (AD) is a field with huge unmet need and only a few symptomatic treatments with limited efficacy have been made available to patients. With the testing of disease-modifying drugs in recent years, the ...
-
(Massachusetts Institute of Technology, 1989)
-
(Massachusetts Institute of Technology, 1992)
-
(Massachusetts Institute of Technology, 2011)The influence of middle-ear disease on hearing in mice is not well understood. We investigated middle-ear function and structure in a small group of dopamine beta hydroxylase (DBH)- knockout mice, which are known to be ...
-
(Massachusetts Institute of Technology, 2008)Large pharmaceutical companies (Multinational Pharmaceutical Companies or MPCs) have struggled in recent years with the rapidly accelerating costs of drug-discovery research and development. These costs continue to rise ...
-
(Massachusetts Institute of Technology, 2007)Venture capital investment performance data and performance attribution are not typically published. Venture investors articulate (and sell to LPs) conflicting strategies; the popular business literature and culture is ...
-
(Massachusetts Institute of Technology, 1997)
-
(Massachusetts Institute of Technology, 2009)Introduction. Models for mortality prediction are traditionally developed from prospective multi-center observational studies involving a heterogeneous group of patients to optimize external validity. We hypothesize that ...
-
(Massachusetts Institute of Technology, 2004)The focus of this study was to investigate the histology of tissue formed when fetal (16-20 days gestation) and neonatal (2 days old) rat lung cells were grown in a collagen-glycosaminoglycan scaffold. This project employed ...
-
(Massachusetts Institute of Technology, 2004)One important purpose for creating clinical practice guidelines is to improve quality of care by reducing variations in practice. In the current healthcare environment, guidelines are being advocated as a means to disseminate ...
Browse
My Account
MIT-Mirage